BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1865 related articles for article (PubMed ID: 9550393)

  • 1. Strength of TCR signal determines the costimulatory requirements for Th1 and Th2 CD4+ T cell differentiation.
    Tao X; Constant S; Jorritsma P; Bottomly K
    J Immunol; 1997 Dec; 159(12):5956-63. PubMed ID: 9550393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies using antigen-presenting cells lacking expression of both B7-1 (CD80) and B7-2 (CD86) show distinct requirements for B7 molecules during priming versus restimulation of Th2 but not Th1 cytokine production.
    Schweitzer AN; Sharpe AH
    J Immunol; 1998 Sep; 161(6):2762-71. PubMed ID: 9743334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of CTLA-4 in regulating Th2 differentiation.
    Oosterwegel MA; Mandelbrot DA; Boyd SD; Lorsbach RB; Jarrett DY; Abbas AK; Sharpe AH
    J Immunol; 1999 Sep; 163(5):2634-9. PubMed ID: 10453003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The capacity of the natural ligands for CD28 to drive IL-4 expression in naïve and antigen-primed CD4+ and CD8+ T cells.
    Bian Y; Hiraoka S; Tomura M; Zhou XY; Yashiro-Ohtani Y; Mori Y; Shimizu J; Ono S; Dunussi-Joannopoulos K; Wolf S; Fujiwara H
    Int Immunol; 2005 Jan; 17(1):73-83. PubMed ID: 15569772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptide dose, affinity, and time of differentiation can contribute to the Th1/Th2 cytokine balance.
    Rogers PR; Croft M
    J Immunol; 1999 Aug; 163(3):1205-13. PubMed ID: 10415015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical role of costimulation in the activation of naive antigen-specific TCR transgenic CD8+ T cells in vitro.
    Chai JG; Vendetti S; Bartok I; Schoendorf D; Takacs K; Elliott J; Lechler R; Dyson J
    J Immunol; 1999 Aug; 163(3):1298-305. PubMed ID: 10415027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of costimulators in T cell differentiation: studies using antigen-presenting cells lacking expression of CD80 or CD86.
    Schweitzer AN; Borriello F; Wong RC; Abbas AK; Sharpe AH
    J Immunol; 1997 Mar; 158(6):2713-22. PubMed ID: 9058805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effect of CTLA4Ig on murine graft-versus-host disease (GVHD) development: CTLA4Ig prevents both acute and chronic GVHD development but reverses only chronic GVHD.
    Via CS; Rus V; Nguyen P; Linsley P; Gause WC
    J Immunol; 1996 Nov; 157(9):4258-67. PubMed ID: 8892665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High concentrations of antigenic ligand activate and do not tolerize naive CD4 T cells in the absence of CD28/B7 costimulation.
    Teh HS; Teh SJ
    Cell Immunol; 1997 Jul; 179(1):74-83. PubMed ID: 9259774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigen-dependent clonal expansion of a trace population of antigen-specific CD4+ T cells in vivo is dependent on CD28 costimulation and inhibited by CTLA-4.
    Kearney ER; Walunas TL; Karr RW; Morton PA; Loh DY; Bluestone JA; Jenkins MK
    J Immunol; 1995 Aug; 155(3):1032-6. PubMed ID: 7543510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD28 costimulation accelerates IL-4 receptor sensitivity and IL-4-mediated Th2 differentiation.
    Kubo M; Yamashita M; Abe R; Tada T; Okumura K; Ransom JT; Nakayama T
    J Immunol; 1999 Sep; 163(5):2432-42. PubMed ID: 10452978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4 regulation of TCR signaling and T cell differentiation following stimulation with peptides of different affinities for the TCR.
    Leitenberg D; Boutin Y; Constant S; Bottomly K
    J Immunol; 1998 Aug; 161(3):1194-203. PubMed ID: 9686579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation.
    Salomon B; Bluestone JA
    Annu Rev Immunol; 2001; 19():225-52. PubMed ID: 11244036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naive and effector CD4 T cells differ in their requirements for T cell receptor versus costimulatory signals.
    Dubey C; Croft M; Swain SL
    J Immunol; 1996 Oct; 157(8):3280-9. PubMed ID: 8871622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and contribution of B7-1 (CD80) and B7-2 (CD86) in the early immune response to Leishmania major infection.
    Elloso MM; Scott P
    J Immunol; 1999 Jun; 162(11):6708-15. PubMed ID: 10352289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD28/B7 interactions deliver a unique signal to naive T cells that regulates cell survival but not early proliferation.
    Sperling AI; Auger JA; Ehst BD; Rulifson IC; Thompson CB; Bluestone JA
    J Immunol; 1996 Nov; 157(9):3909-17. PubMed ID: 8892622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of blockade of CD28-B7 on the development of Th1 or Th2 effector cells in experimental leishmaniasis.
    Corry DB; Reiner SL; Linsley PS; Locksley RM
    J Immunol; 1994 Nov; 153(9):4142-8. PubMed ID: 7523517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polarization of naive CD4+ T cells toward the Th1 subset by CTLA-4 costimulation.
    Kato T; Nariuchi H
    J Immunol; 2000 Apr; 164(7):3554-62. PubMed ID: 10725710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD28, Ox-40, LFA-1, and CD4 modulation of Th1/Th2 differentiation is directly dependent on the dose of antigen.
    Rogers PR; Croft M
    J Immunol; 2000 Mar; 164(6):2955-63. PubMed ID: 10706682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The number of responding CD4 T cells and the dose of antigen conjointly determine the TH1/TH2 phenotype by modulating B7/CD28 interactions.
    Rudulier CD; McKinstry KK; Al-Yassin GA; Kroeger DR; Bretscher PA
    J Immunol; 2014 Jun; 192(11):5140-50. PubMed ID: 24752446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 94.